Sequenom, Inc. (NASDAQ:SQNM)

CAPS Rating: 2 out of 5

A genetics company committed to providing genetic analysis products and services that translate genomic science into superior solutions for the biomedical research, molecular medicine, agricultural, and non-invasive prenatal testing markets.

Recs

0
Player Avatar IdahoAve (79.78) Submitted: 10/23/2009 10:41:07 AM : Outperform Start Price: $3.34 SQNM Score: -77.75

I am gambling with this one. I am hoping the mishandlings in the T21 test were due to incompetant oversite, rather than inadequate science. I try to be the buyer of bad news, however I am having great difficulty pulling th tricker on this one.

Go SQNM and please make a commercially non-viable prenatal down syndrom test and make me out to look like a genius as your stock price skyrockets into the deep $30s

Featured Broker Partners


Advertisement